SUMMIT data for bezuclastinib in NonAdvSM selected for two oral presentations which will describe its best-in-class potential ...

Additionally, the more than 50 abstracts accepted at ASH include new and updated data from Incyte’s MPN, GVHD and hematology ...

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines in oncology ...

Toyota’s most popular pickup is finally going electric, or at least that’s what a leaked internal presentation slide seems to ...

Pharmaceuticals announced that 23 abstracts, including six oral presentations, showcasing compelling Revuforj and Niktimvo data were accepted for presentation at the 67th American Society of ...

From reference managers to note-taking apps, and presentation tools, the research and writing process is getting a high-tech ...

Defensive back Honor Fa’alave-Johnson (San Diego, California/ Cathedral Catholic High School) was officially honored as a ...

Developed by Ascentage Pharma, olverembatinib is the first China-approved third-generation BCR-ABL inhibitor, currently being jointly commercialized in China by Ascentage Pharma and Innovent Biologics ...

1. Naturally, there’s a strong learning component. The stated aim of this type of showcase is for all attendees to learn ...

Upload an image to instantly find the perfect design from a library of over 800,000 templates Create your ideal brand mood in ...

Q3 2025 Earnings Call November 3, 2025 8:30 AM ESTCompany ParticipantsJohn Kasel - President, CEO & DirectorWilliam Thalman ...